Author

Jodell Dahl

Observed name: J.L. Dahl

Institution: University of Minnesota

Observed institution: University of Minnesota

OpenAlex ID: A5040788629

Phase I trial of ontuxizumab (MORAb-004) in children with relapsed or refractory solid tumors: A Children’s Oncology Group Study.

2015 · Robin Elizabeth Norris, Elizabeth Fox, et al. · Journal of Clinical Oncology · 3

Cancer pain, opioids and the law: balancing drug control and availability

1990 · D.E. Joranson, J.L. Dahl, et al. · Pain · 1

Successful Opioid De-Escalation With Dexmedetomidine in a 1 year old with Worsening Pain and Opioid-Induced Neurotoxicity

2018 · Naomi Goloff, Jodell Dahl · PEDIATRICS

Works count: 3

Citation count: 4

H-index: 1

I10-index: